Do treatment patterns alter beliefs cancer patients hold regarding oral oncolytic agents?
dc.contributor.author | Sikorskii, Alla | |
dc.contributor.author | Given, Charles W. | |
dc.contributor.author | Given, Barbara A. | |
dc.contributor.author | Vachon, Eric | |
dc.contributor.author | Marshall, Victoria | |
dc.contributor.author | Krauss, John C. | |
dc.contributor.author | Banik, Asish | |
dc.contributor.author | Majumder, Atreyee | |
dc.date.accessioned | 2018-03-07T18:24:23Z | |
dc.date.available | 2019-05-13T14:45:24Z | en |
dc.date.issued | 2018-03 | |
dc.identifier.citation | Sikorskii, Alla; Given, Charles W.; Given, Barbara A.; Vachon, Eric; Marshall, Victoria; Krauss, John C.; Banik, Asish; Majumder, Atreyee (2018). "Do treatment patterns alter beliefs cancer patients hold regarding oral oncolytic agents?." Psycho‐Oncology 27(3): 1005-1012. | |
dc.identifier.issn | 1057-9249 | |
dc.identifier.issn | 1099-1611 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/142470 | |
dc.description.abstract | ObjectiveCancer patients, particularly those prescribed with oral oncolytic medications, face treatment side effects and temporary and permanent stoppages of treatment. This research examines how events during treatment affect patients’ beliefs regarding oral oncolytic medications.MethodsA total of 272 cancer patients initiating 1 of 28 oral oncolytic agents were followed for 12 weeks. Assessments of Beliefs About Medications Questionnaire, symptoms, physical function, and depression measures were performed during telephone interviews at intake (medication start) and 4, 8, and 12 weeks. Electronic medical record audits identified dates of temporary and permanent medication stoppages. Linear mixed‐effects models were used for longitudinal analyses of the Beliefs About Medications Questionnaire scores in relation to patient characteristics, symptom severity, and medication stoppages.ResultsOver the initial 12 weeks, beliefs about the necessity of oral medications have increased, concerns have decreased, and interference of medications with daily lives has increased. Permanent stoppage of a medication predicted significant declines in beliefs about its necessity over time. Male patients, those less educated, those reporting higher symptom severity, and those experiencing temporary stoppages had greater concerns. Interference of medications with daily life was higher for males, increased with higher symptom severity, and differed by drug category.ConclusionsPatients’ beliefs in the necessity of their oral medication were affected only by a permanent drug stoppage. Symptom severity, education, and patient sex affected patients’ beliefs about their concerns with their medications and the interference medications posed for their daily lives. Interventions may need to target the distinct dimensions of beliefs during treatment with oral oncolytic agents. | |
dc.publisher | Wiley Periodicals, Inc. | |
dc.subject.other | cancer | |
dc.subject.other | late stage disease | |
dc.subject.other | medication beliefs | |
dc.subject.other | medication stoppages | |
dc.subject.other | oncology | |
dc.subject.other | oral oncolytic medications | |
dc.subject.other | symptoms | |
dc.title | Do treatment patterns alter beliefs cancer patients hold regarding oral oncolytic agents? | |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | |
dc.subject.hlbsecondlevel | Hematology and Oncology | |
dc.subject.hlbtoplevel | Health Sciences | |
dc.description.peerreviewed | Peer Reviewed | |
dc.description.bitstreamurl | https://deepblue.lib.umich.edu/bitstream/2027.42/142470/1/pon4606.pdf | |
dc.description.bitstreamurl | https://deepblue.lib.umich.edu/bitstream/2027.42/142470/2/pon4606_am.pdf | |
dc.identifier.doi | 10.1002/pon.4606 | |
dc.identifier.source | Psycho‐Oncology | |
dc.identifier.citedreference | Timmers L, Boons CC, Kropff F, et al. Adherence and patients’ experiences with the use of oral anticancer agents. Acta Oncol. 2014; 53 ( 2 ): 259 ‐ 267. | |
dc.identifier.citedreference | Horne R, Weinman J. Patients’ beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res. 1999; 47 ( 6 ): 555 ‐ 567. | |
dc.identifier.citedreference | Horne R, Weinman J, Hankins M. The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health. 1999; 14 ( 1 ): 1 ‐ 24. | |
dc.identifier.citedreference | Becker MH. The health belief model and sick role behavior. Health Educ Quart. 1974; 2: 409 ‐ 419. | |
dc.identifier.citedreference | Janz NK, Becker MH. The health belief model: a decade later. Health Educ Behav. 1984; 11 ( 1 ): 1 ‐ 47. | |
dc.identifier.citedreference | Rosenstock IM. Historical origins of the health belief model. Health Educ Quart. 1974; 2: 328 ‐ 335. | |
dc.identifier.citedreference | Horne R, Chapman SCE, Parham R, Freemantle N, Forbes A, Cooper V. Understanding patients’ adherence‐related beliefs about medicines prescribed for long‐term conditions: a meta‐analytic review of the necessity‐concerns framework. PLoS One. 2013; 8 ( 12 ): e80633 | |
dc.identifier.citedreference | Andersson Sundell K, Jonsson AK. Beliefs about medicines are strongly associated with medicine‐use patterns among the general population. Int J Clin Pract. 2016; 70 ( 3 ): 277 ‐ 285. | |
dc.identifier.citedreference | Kumar K, Raza K, Nightingale P, et al. Determinants of adherence to disease modifying anti‐rheumatic drugs in white British and South Asian patients with rheumatoid arthritis: a cross sectional study. BMC Musculoskelet Disord. 2015; 16 ( 1 ): 396 | |
dc.identifier.citedreference | Bhattacharya D, Easthall C, Willoughby KA, Small M, Watson S. Capecitabine non‐adherence: exploration of magnitude, nature and contributing factors. J Oncol Pharm Pract. 2012; 18 ( 3 ): 333 ‐ 342. | |
dc.identifier.citedreference | Timmers L, Boons CC, Mangnus D, et al. Adherence and patients’ experiences with the use of capecitabine in daily practice. Front Pharmacol. 2016; 7: article 310 | |
dc.identifier.citedreference | De las Cuevas C, de Leon J. Reviving research on medication attitudes for improving pharmacotherapy: focusing on adherence. Psychother Psychosom. 2017; 86 ( 2 ): 73 ‐ 79. | |
dc.identifier.citedreference | Devlen J, Beusterien K, Yen L, Ahmed A, Cheifetz AS, Moss AC. Barriers to mesalamine adherence in patients with inflammatory bowel disease: a qualitative analysis. J Manag Care Spec Pharm. 2014; 20 ( 3 ): 309 ‐ 314. | |
dc.identifier.citedreference | Michetti P, Weinman J, Mrowietz U, et al. Impact of treatment‐related beliefs on medication adherence in immune‐mediated inflammatory diseases: results of the global ALIGN study. Adv Ther. 2017; 34 ( 1 ): 91 ‐ 108. | |
dc.identifier.citedreference | Náfrádi L, Galimberti E, Nakamoto K, Schulz PJ. Intentional and unintentional medication non‐adherence in hypertension: the role of health literacy, empowerment and medication beliefs. J Public Health Res. 2016; 5 ( 3 ): 762 | |
dc.identifier.citedreference | Salgado TM, Davis EJ, Farris KB, Fawaz S, Batra P, Henry NL. Identifying socio‐demographic and clinical characteristics associated with medication beliefs about aromatase inhibitors among postmenopausal women with breast cancer. Breast Cancer Res Treat. 2017; 163 ( 2 ): 311 ‐ 319. | |
dc.identifier.citedreference | Given BA, Given CW. Improving adherence to oral cancer agents and self care of symptoms using an IVR. National Cancer Intstitute grant number 1R01CA162401‐01A1. 2013 ‐2017 | |
dc.identifier.citedreference | Horne R, Buick D, Fisher M, Leake H, Cooper V, Weinman J. Doubts about necessity and concerns about adverse effects: identifying the types of beliefs that are associated with non‐adherence to HAART. Int J STD AIDS. 2004 Jan; 15 ( 1 ): 38 ‐ 44. | |
dc.identifier.citedreference | Radloff LS. The CES‐D Scale: a self‐report depression scale for research in the general population. Appl Psychol Measur. 1977; 1 ( 3 ): 385 ‐ 401. | |
dc.identifier.citedreference | Cella D, Young S, Rothrock N, et al. The patient‐reported outcomes measurement information system (PROMIS): progress of an NIH roadmap cooperative group during its first two years. Med Care. 2007; 45 ( 5 Suppl ): S3 ‐ S11. | |
dc.identifier.citedreference | PROMIS. Adult physical function profile short forms. 2013. http://assessmentcenter.net Accessed May 1, 2017. | |
dc.identifier.citedreference | Foot H, La Caze A, Gujral G, Cottrell N. The necessity‐concerns framework predicts adherence to medication in multiple illness conditions: a meta‐analysis. Patient Educ Couns. 2016; 99 ( 5 ): 706 ‐ 717. | |
dc.identifier.citedreference | De Smedt RH, Denig P, van der Meer K, Haaijer‐Ruskamp FM, Jaarsma T. Self‐reported adverse drug events and the role of illness perception and medication beliefs in ambulatory heart failure patients: a cross‐sectional survey. Int J Nurs Stud. 2011; 48 ( 12 ): 1540 ‐ 1550. | |
dc.identifier.citedreference | Grassi L, Meggiolaro E, Berardi MA, et al. Beliefs about medicines, doctor‐patient relationship, and coping among European patients with cancer. Psycho‐Oncol. 2017; 26 ( 2 ): 282 ‐ 285. | |
dc.identifier.citedreference | Aikens JE, Piette JD. Diabetic patients’ medication underuse, illness outcomes, and beliefs about antihyperglycemic and antihypertensive treatments. Diabetes Care. 2009; 32 ( 1 ): 19 ‐ 24. | |
dc.identifier.citedreference | Federman AD, Wolf M, Sofianou A, et al. The association of health literacy with illness and medication beliefs among older adults with asthma. Patient Educ Couns. 2013; 92 ( 2 ): 273 ‐ 278. | |
dc.identifier.citedreference | Weingart SN, Brown E, Bach PB, et al. NCCN task force report: oral chemotherapy. J Natl Compr Canc Netw. 2008; 6 ( 3 ): S1 ‐ S16. | |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.